本次会计政策变更是中农立华生物科技股份有限公司（以下简称"公 司""本公司"）根据中华人民共和国财政部（以下简称"财政部"）颁布的《企 业会计准则解释第 16 号》（财会〔2022〕31 号，以下简称"《准则解释第 16 号》"） 的要求，对公司会计政策、相关会计科目核算和列报进行适当的变更和调整。 中农立华生物科技股份有限公司 关于会计政策变更的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、概述 2022年11月30日，财政部发布了《准则解释第16号》，明确规定"关于单项 交易产生的资产和负债相关的递延所得税不适用初始确认豁免的会计处理"等内 容。本公司自2023年1月1日起执行"关于单项交易产生的资产和负债相关的递延 所得税不适用初始确认豁免的会计处理"的规定。 二、会计政策变更的具体情况及对公司的影响 证券代码：603970 证券简称：中农立华 公告编号：2023-022 内容自2023年1月1日起施行。 （二）本次会计政策变更主要内容 本次会计政策变更前，公司执行财政部颁布的《企业会计准则— ...

证券代码：603970 证券简称：中农立华 中农立华生物科技股份有限公司 投资者关系活动记录表 编号：2023-01 ☑特定对象调研 分析师会议 媒体采访 业绩说明会 投资者关 系活动类 别 新闻发布会 路演活动 ☑现场参观 ☑网络会议 ☑一对一沟通 其他 财通证券股份有限公司 余剑秋、王宇璇、费津皖 天风证券股份有限公司 林逸丹、刘思远 广东弘信达私募股权投资基金管理有限公司 黄文希 参与单位 名称及人 员姓名 大成基金管理有限公司 韩创 中金公司资产管理部 彭祺程 富国基金管理有限公司 蒲世林 长信基金管理有限责任公司 许望伟、齐菲 时间 2023 年 4 月 19 日、5 月 8 日、5 月 16 日、5 月 17 日、5 月 19 日、5 月 22 日、5 月 31 日、6 月 6 日 地点 中农立华会议室、线上会议 上市公司 接待人员 姓名 公司总经理兼董事会秘书黄柏集先生 公司党总支部副书记、副总经理及证券事务代表常青女士 1.管理层介绍公司情况 中农立华是中华全国供销合作总社下属唯一农化流通上市平台。 公司自 2009 年从中国农业生产资料集团有限公司（以下简称"中农 集团"）农药部改制成立，2 ...

Financial Performance - The company's operating revenue for Q1 2023 was CNY 2,343,089,117.74, representing a year-on-year increase of 15.17%[4] - The net profit attributable to shareholders for the same period was CNY 53,639,248.87, reflecting a growth of 20.48% compared to the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 50,278,445.49, which is an increase of 25.07% year-on-year[4] - The basic earnings per share for Q1 2023 was CNY 0.2794, up by 20.48% from the same period last year[4] - The weighted average return on equity increased by 0.29 percentage points to 3.97%[4] - The net profit for Q1 2023 was CNY 59,163,021.36, an increase of 14.3% compared to CNY 51,567,888.42 in Q1 2022[19] - The total revenue for Q1 2023 was CNY 83,636,882.88, up from CNY 68,235,273.02 in the same period last year, reflecting a growth of approximately 22.4%[19] - The operating profit for Q1 2023 reached CNY 83,707,683.33, compared to CNY 67,419,735.07 in Q1 2022, marking an increase of 24.2%[19] - The basic and diluted earnings per share for Q1 2023 were both CNY 0.2794, up from CNY 0.2319 in Q1 2022, representing a growth of 20.5%[20] - The total comprehensive income for Q1 2023 was CNY 59,134,963.50, compared to CNY 51,560,498.00 in Q1 2022, indicating an increase of 14.7%[20] Cash Flow and Assets - The net cash flow from operating activities was negative at CNY -771,439,540.60, primarily due to increased operational payments[4][6] - Cash and cash equivalents decreased to ¥523,645,821.94 as of March 31, 2023, from ¥1,931,722,075.70 at the end of 2022, a decline of 72.9%[12] - Cash and cash equivalents at the end of Q1 2023 totaled CNY 402,830,765.85, a decrease from CNY 331,562,729.68 in Q1 2022[23] - The company reported cash inflows from investment activities of CNY 303,877,150.00 in Q1 2023, down from CNY 818,408,978.68 in Q1 2022[22] - The company incurred a total of CNY 2,781,190,064.69 in cash outflows from operating activities in Q1 2023, compared to CNY 2,543,278,065.70 in Q1 2022[22] Assets and Liabilities - The total assets at the end of the reporting period were CNY 5,854,501,104.92, a decrease of 6.24% compared to the end of the previous year[4] - Total assets decreased to ¥5,854,501,104.92 as of March 31, 2023, down from ¥6,244,026,226.63 at the end of 2022, a reduction of 6.2%[14] - Total liabilities decreased to ¥4,310,840,845.76 as of March 31, 2023, compared to ¥4,759,500,930.97 at the end of 2022, a decline of 9.4%[14] - The company’s total liabilities decreased to CNY 1,185,187,103.65 in Q1 2023 from CNY 500,835,228.03 in Q1 2022, reflecting a reduction in financial leverage[23] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,134[8] - The largest shareholder, China Agricultural Materials Group Co., Ltd., holds 50.25% of the shares[8] Research and Development - Research and development expenses increased to ¥6,600,786.46 in Q1 2023, compared to ¥4,570,578.72 in Q1 2022, reflecting a growth of 44.4%[18] - The company is focusing on expanding its market presence and enhancing its product offerings through increased R&D investment[18] Accounts Receivable and Inventory - Accounts receivable rose significantly to ¥713,498,542.50 in Q1 2023, compared to ¥251,538,001.49 in Q4 2022, marking an increase of 184.5%[12] - Inventory levels increased to ¥2,232,001,593.17 as of March 31, 2023, up from ¥1,562,869,582.78 at the end of 2022, representing a growth of 42.7%[12]

Financial Performance - In 2022, the company achieved a net profit of RMB 148,250,292.47, with total distributable profits amounting to RMB 645,855,331.11 after accounting for dividends and reserves[6]. - The proposed cash dividend is RMB 5.50 per 10 shares, totaling RMB 105,600,052.80, which represents 50.21% of the net profit for the year[7]. - The company's operating revenue for 2022 was CNY 11.698 billion, representing a 32.61% increase compared to CNY 8.822 billion in 2021[26]. - The net profit attributable to shareholders for 2022 was CNY 210.333 million, a 23.50% increase from CNY 170.309 million in 2021[26]. - The net profit after deducting non-recurring gains and losses was CNY 198.936 million, up 24.77% from CNY 159.439 million in 2021[26]. - The net cash flow from operating activities reached CNY 1.536 billion, a significant increase of 371.89% compared to CNY 325.419 million in 2021[26]. - The total assets at the end of 2022 were CNY 6.244 billion, reflecting a 31.68% increase from CNY 4.742 billion at the end of 2021[26]. - The basic earnings per share for 2022 was CNY 1.0952, up 23.51% from CNY 0.8870 in 2021[27]. - The weighted average return on equity increased to 16.91% in 2022 from 15.63% in 2021[28]. Risk Management - The company has not identified any significant risks that could materially affect its operations during the reporting period[10]. - The company emphasizes the importance of risk awareness in its forward-looking statements, advising investors to consider potential investment risks[8]. - The company has not faced any violations in decision-making procedures regarding external guarantees[9]. - The company has committed to ensuring the accuracy and completeness of its financial reports, as confirmed by the external auditor's standard unqualified opinion[5]. Strategic Development - The company has a comprehensive strategy for future development, although specific details are not disclosed in the summary[10]. - The company launched new products such as "Zhongnong Jingzhi," "Daqi," and "Youzuo," with significant sales performance, including over CNY 100 million in sales for the "Fuliya" product[36]. - The company expanded its international business by enhancing core product sales and implementing brand renewal projects in international markets[37]. - The company is committed to optimizing its product structure and reducing costs, with ongoing research and development of new agricultural machinery products[37]. - The company aims to enhance operational capabilities and service efficiency through logistics information upgrades and customer engagement[37]. Market Conditions - The raw material price index reported a decline of 32.7% year-on-year as of December 25, 2022, with 79% of product prices decreasing, impacting the agricultural chemical industry[38]. - The company faced challenges in the agricultural chemical market due to supply exceeding demand, leading to a significant drop in raw material transaction volumes[39]. - The demand for pesticides is expected to remain stable due to the emphasis on food security amid global political instability and rising international grain prices[89]. - The domestic pesticide market is anticipated to see increased concentration and intensified competition, with stronger companies expanding upstream and downstream[90]. Corporate Governance - The company has no penalties from securities regulatory agencies in the past three years[113]. - The company has no significant issues in corporate governance as per the self-inspection conducted[139]. - The company has established an incentive mechanism for core management and key employees as discussed in the board meeting on August 18, 2022[114]. - The total remuneration for all directors, supervisors, and senior management personnel at the end of the reporting period was 8.0387 million yuan[111]. Research and Development - The company is committed to research and development in new technologies to improve agricultural practices and product offerings[106]. - Research and development expenses rose to ¥45,785,963.73, marking a 22.01% increase from ¥37,527,549.23 in the prior year[55]. - The total R&D expenditure accounted for 0.39% of the operating revenue, with no capitalized R&D expenses reported[65]. - The number of R&D personnel is 145, accounting for 16.84% of the total workforce[66]. Social Responsibility - The company has invested ¥36.79 million in environmental protection during the reporting period[140]. - The company conducted over 10,100 technical training service activities in 2022 to support farmers with pest control solutions[146]. - The company donated a total of CNY 300,000 to educational institutions, including CNY 200,000 to Jilin Agricultural University and CNY 100,000 to Yangtze University[145]. - The company is actively promoting the "green agricultural materials" initiative by introducing efficient, low-toxicity products and enhancing recycling efforts[146]. Financial Management - The company has a cash dividend policy that ensures a minimum distribution of 20% of the distributable profit each year, with a total cash dividend amount of ¥105,600,052.80, accounting for 50.21% of the net profit attributable to ordinary shareholders[134][135]. - The company has a total of 1 billion RMB in bank wealth management, with an outstanding balance of 1 billion RMB[173]. - The company has successfully recovered all structured deposits, indicating effective cash management strategies[176]. - The company has engaged in cash asset management through entrusted wealth management, indicating a proactive approach to asset growth[172]. Employee Management - The company has implemented training programs for employees, combining internal and external training methods, including remote video conferencing for dispersed staff[130]. - The company has established a competitive salary and bonus structure to attract and retain talent, with performance incentives linked to annual performance goals[128]. - The total number of employees in the parent company and major subsidiaries is 861, with 257 in the parent company and 604 in subsidiaries[127]. - The company has a total of 861 employees, with 489 holding a bachelor's degree or higher[127].

证券代码：603970 证券简称：中农立华 公告编号：2023-002 中农立华生物科技股份有限公司 关于召开 2022 年度暨 2023 年第一季度业绩说明会的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2023 年 4 月 21 日(星期五) 上午 10:00-11:00 会议召开地点：上海证券交易所上证路演中心（网址： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2023 年 4 月 14 日(星期五) 至 4 月 20 日(星期 四)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或 通过公司邮箱 sal@sino-agri-sal.com 进行提问。公司将在说明会上对 投资者普遍关注的问题进行回答。 中农立华生物科技股份有限公司（以下简称"公司"）将于 2023 年 4 月 19 日发布公司 2022 年年度报告和 2023 年第一季度报告，为 便于广大投资者更全面深入地了解公司 2022年度和202 ...

Group 1: Company Overview - Zhongnong Lihua Biotechnology Co., Ltd. was established in 2009 and is the first company listed on the Chinese IPO market under the China Agricultural Production Materials Group, the largest agricultural production materials supplier in China, accounting for 10% of the national agricultural materials sales [1]. - The company has maintained steady annual growth since its establishment, with significant sales increases in recent years [2]. Group 2: Financial Performance - Sales reached CNY 6.6 billion in 2020 and CNY 8.8 billion in 2021, with a profit increase of nearly 30% year-on-year. The company expects continued growth in sales and profits for the current year [2]. - The company aims to double its performance and sales over the next five years [2]. Group 3: Business Segments - The company operates six major business segments, including two unique segments that cannot be replicated by other domestic agricultural suppliers: - Collaboration with international agrochemical companies to establish a joint sales platform, generating CNY 3 billion in sales last year [2]. - A service platform for domestic agrochemical enterprises, which supported 1,500 pesticide manufacturers and achieved CNY 2.5 billion in sales last year [2]. - The international business segment has seen significant growth, with pesticide exports increasing from over CNY 100 million five years ago to CNY 2.5 billion in 2021, with over 140 overseas registrations [2]. Group 4: Future Development - The company plans to focus on crop health services and has conducted over 10,000 promotional events in 2021 to improve farmers' application of agricultural chemicals [2]. - The company is also advancing into the seed industry, with plans to participate in cooperative projects and leverage its advantages in seed resources and distribution networks [3]. Group 5: Impact of COVID-19 - The pandemic has caused production halts and logistics disruptions, but demand remains stable due to the essential nature of agriculture and government focus on food security [3]. - The company has prepared for potential disruptions by enhancing its warehousing network, which has mitigated some logistical challenges [3]. Group 6: Pricing and Supply Chain - Raw material prices surged due to the pandemic, but the company managed to mitigate impacts through early stockpiling and strategic planning [3]. - The company is developing a pricing index for raw materials to enhance its influence in the industry and create a trading platform [3]. Group 7: International Expansion - The company has established subsidiaries in key agricultural countries in Latin America, including Argentina and Colombia, and plans to develop its presence in Brazil [5].

2022 年第三季度报告 证券代码：603970 证券简称：中农立华 中农立华生物科技股份有限公司 2022 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 单位：元 币种：人民币 | | | 本报告期 | | 年初至报告 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 比上年同 期增减变 | 年初至报告期末 | 期末比上年 同期增减变 | | | | 动幅度(%) | | 动幅度(%) | | 营业收入 | 3,590,830,130.34 | 38.23 | 9,684,451,697.31 | 29.56 | | 归属于上市公司股东的净利润 | 30,482,161.17 | 21.16 | 169,341,949.31 | 23.70 | | 归属于上市公司股东的扣除非 经常性损益的净利润 | ...

Financial Performance - The company reported a total revenue of 1.2 billion RMB for the first half of 2022, representing a year-on-year increase of 15%[19] - The net profit attributable to shareholders was 200 million RMB, up 10% compared to the same period last year[19] - The company's operating revenue for the first half of the year reached ¥6,093,621,566.97, representing a year-on-year increase of 24.94% compared to ¥4,877,180,138.60[20] - Net profit attributable to shareholders was ¥138,859,788.14, up 24.28% from ¥111,732,385.11 in the same period last year[20] - The net profit after deducting non-recurring gains and losses was ¥133,242,691.66, reflecting a 29.91% increase from ¥102,569,140.71[20] - The company's total assets increased by 44.03% to ¥6,829,524,931.03 from ¥4,741,703,753.83 at the end of the previous year[20] - Basic earnings per share rose to ¥0.7232, a 24.28% increase from ¥0.5819 in the same period last year[21] - The weighted average return on equity increased by 0.89 percentage points to 11.12% from 10.23%[22] - The company's total assets at the end of the reporting period amount to CNY 1,255,932,718.34[140] Market Expansion and Strategy - Future guidance indicates an expected revenue growth of 20% for the second half of 2022, driven by new product launches and market expansion strategies[19] - Market expansion efforts include entering three new provinces, which are projected to contribute an additional 150 million RMB in revenue by the end of 2022[19] - The company is actively expanding its international market presence, with operations in over 80 countries and regions[27] - The company is focusing on enhancing its international business by strengthening sales to key customers and core products, particularly in the Americas and Europe[44] - The company has established a comprehensive agricultural service network, with 31 warehousing and distribution centers and over 3,000 main channel partners across China[36] Research and Development - The company is investing 100 million RMB in R&D for new agricultural technologies, aiming to enhance product efficiency and sustainability[19] - The company is committed to developing new agricultural chemical products and providing tailored crop health solutions to enhance brand influence among farmers[30] - Research and development expenses rose by 9.24% to ¥11,454,761.74 from ¥10,485,492.81, reflecting increased investment in R&D[48] - The company is committed to advancing green pesticide research and development, collaborating with leading agricultural research institutions to enhance its technological capabilities[37] Operational Efficiency - The company has established a strong supply chain and logistics system, integrating self-owned and third-party logistics to enhance service efficiency[29] - The company plans to enhance service efficiency through factory upgrades and the application of information technology in supply chain management[45] - The company signed cooperation agreements with 120 major pesticide manufacturers to ensure stable supply chains during the spring farming season, addressing transportation issues caused by pandemic controls[77] Financial Health and Risks - The company has no significant risks that could materially affect its production and operations during the reporting period[5] - The company faces risks from ongoing global COVID-19 pandemic impacts, including supply chain disruptions and increased raw material prices due to geopolitical tensions[61] - The company is experiencing intensified market competition as the pesticide industry undergoes structural adjustments and transformations[62] - The company has implemented cost and risk control measures, including insurance for inventory and transportation, to mitigate potential losses[43] Shareholder Information - The total number of ordinary shareholders as of the end of the reporting period is 6,185[96] - The largest shareholder, China Agricultural Production Materials Group Corporation, holds 96,480,000 shares, accounting for 50.25% of the total shares[98] - Guangdong Yilong Investment Co., Ltd. is the second-largest shareholder with 18,144,000 shares, representing 9.45%[98] - The company has no significant changes in share capital structure during the reporting period[95] Compliance and Governance - The board of directors confirmed the authenticity and completeness of the financial report, ensuring no major omissions or misleading statements[6] - The company has not proposed any profit distribution or capital reserve transfer plans for this reporting period[4] - There are no non-operational fund occupations by controlling shareholders or related parties reported[5] - The company has not disclosed any significant changes in its environmental impact or compliance with regulations during the reporting period[75] Inventory and Receivables - The company's pesticide export volume was 835,000 tons in the first half of 2022, a year-on-year increase of 9.3%, while the export value reached USD 12.23 billion, up 63.9% year-on-year[32] - The company reported a 722.90% increase in accounts receivable, rising to ¥974,536,531.45 from ¥118,427,437.76, attributed to seasonal effects and sales growth[52] - Inventory increased by 38.59% to ¥2,377,688,546.65 from ¥1,715,607,759.72, mainly due to stockpiling for spring farming supply amid the pandemic[53] Financial Statements and Accounting Policies - The financial statements are prepared based on the principle of continuous operation, reflecting the company's financial position and operating results accurately[151] - The company follows specific accounting policies for bad debt provisions, inventory write-downs, and depreciation of fixed assets, among others[150] - The company applies the expected credit loss model to all financial assets, ensuring that provisions are made based on reasonable and supportable information[167]

2022 年第一季度报告 证券代码：603970 证券简称：中农立华 中农立华生物科技股份有限公司 2022 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务报表 信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比上年同期 | | --- | --- | --- | | | | 增减变动幅度(%) | | 营业收入 | 2,034,514,392.38 | 11.75 | | 归属于上市公司股东的净利润 | 44,521,808.63 | 27.79 | | 归属于上市公司股东的扣除非经常性损益的净利润 | 40,200,995.48 | ...

Financial Performance - The net profit for the year 2021 reached RMB 156,191,677.48, with a total distributable profit of RMB 564,805,072.24 as of December 31, 2021[7]. - The company plans to distribute a cash dividend of RMB 3.5 per 10 shares, totaling RMB 67,200,033.60, which represents 39.46% of the net profit for the year[7]. - The company's operating revenue for 2021 was CNY 8,822,111,307.52, representing a year-on-year increase of 32.84% compared to CNY 6,640,994,269.80 in 2020[26]. - The net profit attributable to shareholders for 2021 was CNY 170,309,383.86, which is a 28.59% increase from CNY 132,443,776.12 in 2020[26]. - The basic earnings per share for 2021 was CNY 0.8870, up 28.59% from CNY 0.6898 in 2020[27]. - The weighted average return on equity increased to 15.63% in 2021, up 2.36 percentage points from 13.27% in 2020[27]. - The total assets at the end of 2021 were CNY 4,741,703,753.83, reflecting a 17.84% increase from CNY 4,024,012,103.50 at the end of 2020[26]. - The net profit after deducting non-recurring gains and losses for 2021 was CNY 159,439,140.70, which is a 34.88% increase from CNY 118,208,657.69 in 2020[26]. - The total net assets attributable to shareholders at the end of 2021 were CNY 1,171,141,107.42, an increase of 14.23% from CNY 1,025,272,662.04 at the end of 2020[26]. - The cost of sales for 2021 was CNY 826,885.45 million, up 35.39% year-on-year, resulting in a comprehensive gross profit margin decrease of 1.77%[63]. Operational Highlights - The company has no significant operational risks that could materially affect its production and operations during the reporting period[10]. - The company has confirmed that there are no non-operating fund occupations by controlling shareholders or related parties[9]. - The company has not violated any decision-making procedures regarding external guarantees[9]. - The company has a history of maintaining a stable and reasonable return for investors through cash dividends[7]. - The company has not faced any significant risks that could impact its future development strategies[10]. - The company emphasizes the importance of investor awareness regarding potential investment risks associated with forward-looking statements[8]. - The company introduced new products for pest control and enhanced agricultural services, focusing on crop health solutions for grain, economic, and specialty crops[34]. - The company has established a stable supply chain and cooperative relationships with upstream and downstream partners to mitigate the impact of external pressures[36]. - The company is enhancing its service efficiency by improving customer engagement and optimizing logistics networks to reduce costs[37]. - The company has developed a targeted crop health solution for different regions and crops, enhancing brand influence among farmers[50]. Research and Development - The company invested CNY 37,527,549.23 in R&D, representing 0.43% of total revenue[71]. - The number of R&D personnel was 135, making up 16% of the total workforce[72]. - The company has 13 technology patents authorized by the national intellectual property office as of 2021, enhancing its R&D and agricultural technology service capabilities[87]. - Research and development expenses increased by 10.25% to 37,527.55 million RMB, supporting the company's focus on green pesticides[61]. - New product development includes a one-piece spray nozzle and research on drift-reducing nozzles and unmanned spray machines[40]. Market Environment - The agricultural chemical industry is experiencing intensified competition, with significant mergers and acquisitions among major players[41]. - The global pesticide industry is highly concentrated, with major companies dominating the high-end market, while China's pesticide industry remains fragmented with low concentration[96]. - The demand for pesticides is stable, driven by the need to ensure national food security amid rising global commodity prices and pest outbreaks[97]. - The industry concentration is expected to increase, with government policies promoting the consolidation of pesticide companies and aiming to reduce the number of producers to below 1,600 by 2025[97]. - The agricultural circulation industry is facing increasing demands for diversified and refined agricultural services, leading to a rise in value-added services as a competitive strategy[86]. Governance and Compliance - The company adheres to strict governance practices, holding regular meetings of the board and committees to ensure compliance and protect shareholder interests[114]. - The company strictly adhered to the information disclosure regulations, ensuring accurate and timely reporting[116]. - The company has no significant differences in governance compared to regulatory requirements[116]. - The company has independent directors and supervisors with extensive experience in various agricultural and financial sectors[124][125][126]. - The company has established a governance structure with clear roles for its board and management[127]. - The company has not reported any non-compliance issues related to its major shareholders or actual controllers[168]. Financial Management - The company has a cash dividend policy that stipulates a minimum distribution of 20% of the distributable profits each year, ensuring stable returns for shareholders[144]. - The company has structured deposits amounting to CNY 496,000,000.00 and bank wealth management products totaling CNY 343,000,000.00, both fully invested[182]. - The company has a total of CNY 50,000,000.00 in a structured deposit with an annualized yield of 3.76%, and CNY 65,000,000.00 in another product with a yield of 3.60%[184]. - The company has not reported any overdue amounts in its financial management activities[182]. - The company has not engaged in any major acquisitions or disposals of assets during the reporting period[170]. Social Responsibility - The company completed the storage task of 1 billion yuan worth of pesticide products for the 2021-2022 National Disaster Relief Pesticide Reserve Project[152]. - The company donated pesticides worth 500,000 yuan to flood-affected areas in Henan Province to assist in agricultural recovery[153]. - The company conducted over 10,000 online and offline activities to provide technical guidance on pesticide application[155]. Risks and Challenges - The ongoing COVID-19 pandemic and global political instability pose risks to the company's operations and export capabilities[107]. - The company faces intensified market competition as the agricultural chemical industry undergoes structural adjustments[108]. - Changes in procurement or sales policies by pesticide manufacturers and distributors could adversely affect the company's performance[109]. - Fluctuations in exchange rates, particularly between the RMB and USD, may impact the company's overall profitability[112].